This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Xarelto
  • /
  • A Study Exploring Two Strategies of Rivaroxaban (J...
Clinical trial

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention (PIONEER AF-PCI)

Read time: 3 mins
Last updated:10th May 2013
Identifier: NCT01830543
Register free for full access to medthority.com